Alberta Minister of Health Tyler Shandro announces the province is working with Novartis Pharmaceuticals Canada Inc. to provide children suffering from spinal muscular atrophy access to the drug Zolgensma.
Canada
Alberta announces interim access to Zolgensma for children suffering from spinal muscular atrophy
More Videos
-
Calgary crash: 9-year-old girl dead after robbery suspect sets off massive Boxing Day collision
-
High speed chase and multi-vehicle crash sends four people to hospital
-
Global Calgary weather specialist Paul Dunphy retires after 51 years in broadcasting
-
B.C. launches campaign to counter Alberta Is Calling initiative
-
Alberta government creates homelessness advisory panel
-
Alberta releases new coal mining policies for the eastern slopes
You are viewing an Accelerated Mobile Webpage.
View Original Article